In vitro activities of linezolid combined with other antimicrobial agents against staphylococci, enterococci, pneumococci, and selected gram-negative organisms

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 1902-1906

  Sweeney, Michael T ^a   Zurenko, Gary E ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; BACITRACIN; CEFALOTIN; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINEZOLID; METICILLIN; METRONIDAZOLE; NALIDIXIC ACID; NORFLOXACIN; NOVOBIOCIN; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; RIFAMPICIN; SPARFLOXACIN; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; TROVAFLOXACIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; DILUTION; DRUG ANTAGONISM; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DRUG ANTAGONISM; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0037764113     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.1902-1906.2003     Document Type: Article

References (23)

1. Allen, A. P., R. Cha, and M. J. Rybak. 2002. In vitro activities of quinupristindalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 46:2602-2612.
2. American Society for Microbiology. 2002. Instructions to authors. Antimicrob. Agents Chemother. 46:i-xix.
3. Baker, C. N., S. N. Banerjee, and F. C. Tenover. 1994. Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gramnegative bacteria. J. Clin. Microbiol. 32:1261-1267.
4. Cappelletty, D. M., and M. J. Rybak. 1996. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:677.
5. Di Pentima, M. C., E. O. Mason, Jr., and S. L. Kaplan. 1998. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin. Infect. Dis. 26:1169-1176.
6. Domaracki, B. E., A. M. Evans, and R. A. Venezia. 2000. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 44:1394-1396.
7. Dresser, L. D., and M. J. Rybak. 1998. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Pharmacotherapy 18:456-462.
8. Ednie, L. M., K. L. Credito, M. Khantipong, M. R. Jacobs, and P. C. Applebaum. 2000. Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods. J. Antimicrob. Chemother. 45:633-638.
9. Eliopoulos, G. M., and C. T. Eliopoulos. 1988. Antibiotic combinations: should they be tested? Clin. Microbiol. Rev. 1:139.
10. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Laboratory methods used to assess the activity of antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
11. Goldstein, E. J., D. M. Citron, and C. V. Merriam. 1999. Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans. Antimicrob. Agents Chemother. 43:1469-1474.
12. Hirschl, A. M., P. Apfalter, A. Makristathis, M. L. Rotter, and M. Wimmer. 2000. In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. Antimicrob. Agents Chemother. 44:1977-1979.
13. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
14. Jorgensen, J. H., M. L. McElmeel, and C. W. Trippy. 1997. In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species. Antimicrob. Agents Chemother. 41:465-467.
15. Mackay, M. L., K. Milne, and I. M. Gould. 2000. Comparison of methods for assessing synergic antibiotic interactions. Int. J. Antimicrob. Agents 15:125-129.
16. Matsumoto, Y. 1998. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae. Chemotherapy (Tokyo) 44:6-9.
17. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Neu, H. C. 1989. Synergy of fluoroquinolones with other antimicrobial agents. Rev. Infect. Dis. 11:S1025-S1035.
19. Noskin, G. A., F. Siddiqui, V. Stosor, D. Hacek, and L. R. Peterson. 1999. In vitro activities of linezolid against important gram-positive bacterial pathogens, including vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 43:2059-2062.
20. Sisson, T. L., G. L. Jungbluth, and N. K. Hopkins. 1999. A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam. J. Clin. Pharmacol. 39:1277-1282.
21. Visalli, M. A., S. Bajaksouzian, M. R. Jacobs, and P. C. Applebaum. 1998. Synergistic activity of trovafloxacin with other agents against gram-positive and -negative organisms. Diagn. Microbiol. Infect. Dis. 30:61-64.
22. Visalli, M. A., M. R. Jacobs, and P. C. Applebaum. 1998. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology. Antimicrob. Agents Chemother. 42:953-955.
23. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.